Skin care advice for breast cancer patients
Part of Cancer, Skin clinical trials.
This study asks a group of expert healthcare professionals to agree on the best ways to care for the skin of breast cancer patients. It uses a step-by-step online survey process to reach consensus.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthcare professional (like a doctor, nurse, or skin specialist).
- You have at least 5–10 years of experience caring for breast cancer patients.
- You work in different types of hospitals or clinics (big centers, local hospitals, etc.) to help make recommendations useful everywhere.
- You can commit to taking part in 2 to 4 rounds of group surveys.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study asks experienced dermatologists to share their expert opinions on using a low-dose medication (isotretinoin) for skin rejuvenation. The goal is to see if there is general agreement on how well it works and how to use it safely.
This study measures how your skin changes physically and mechanically during breast cancer treatment. It may help doctors better manage side effects like skin dryness or tightness.
This trial aims to improve breast cancer care by working together with patients and doctors. It is for people with breast cancer or DCIS (a very early stage), and your input will help shape better care.
This study looks at how changes in the skin’s normal bacteria (microbiome) relate to getting redness, irritation, or rash after breast radiation. It may help doctors predict who is more likely to have skin side effects after reconstruction and radiation.
This study tests a special cream that may prevent skin irritation (radiation dermatitis) caused by radiation therapy for breast cancer. The cream is made from natural weak acids and aims to protect the skin by keeping the skin's microbiome healthy.
This trial looks at how cancer treatments (anti–PD-1/PD-L1/CTLA-4 medicines or CDK inhibitors) affect your skin and overall quality of life. You may fill out questionnaires during the study to help researchers understand changes over time.
Hear when a new Rejuvenation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.